Announcements Trials
Browse Landscape

Status

Recruiting 49Active not recruiting 24Not yet recruiting 10Completed 9Terminated 5Withdrawn 3Unknown 1Suspended 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Other hematologic neoplasm 1

Conditions

Lung Neoplasms 1

Interventions

Carboplatin 133Cisplatin 130Pemetrexed 114Docetaxel 79Drug Therapy 61Gefitinib 57anlotinib 55Gemcitabine 55Erlotinib Hydrochloride 55Radiotherapy 48Bevacizumab 48pembrolizumab 47Paclitaxel 47Etoposide 44apatinib 42icotinib 41camrelizumab 39osimertinib 35Vinorelbine 31Nivolumab 31Radiosurgery 30sintilimab 29aumolertinib 25endostar protein 24durvalumab 24atezolizumab 23Endostatins 22Blood Specimen Collection 19toripalimab 18Immune Checkpoint Inhibitors 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Specimen Handling × Thoracic × Clear all
NCT05641870 2022-12-12

Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC

Parc de Salut Mar

Unknown
80 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡